Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 18, 2026International Journal of Women s HealthOpen Access

CXCL8 Promotes the Progression of Vulvar Squamous Cell Carcinoma and Serves as a Potential Prognostic Biomarker

View Full Paper
Ask AI
Bookmark
Share

Authors

XWXingyan WuYZYongjun ZhangJLJing-Man Li

Discussion

Loading...

Member takes

Overview

Investigation reveals CXCL8 as a prognostic biomarker influencing outcomes in vulvar squamous cell carcinoma, indicating potential therapeutic targets.

Key Points

  • The aim is to explore the role of CXCL8 in vulvar squamous cell carcinoma and its potential as a prognostic biomarker.
  • Analysis of RNA sequencing and GEO database to assess gene expression.
  • Immunohistochemical evaluation of clinical specimens for CXCL8 levels.
  • Functional assays on VSCC cell lines SW962 and A431 to assess proliferation effects.
  • Cell cycle analysis to determine phase transitions induced by CXCL8.
  • Transcriptomic profiling to investigate activated pathways.
  • CXCL8 was found to be differentially expressed in vulvar cancer tissue compared to normal tissue.
  • Higher levels of CXCL8 correlated with shorter progression-free survival and overall survival.
  • CXCL8 enhanced proliferation of VSCC cell lines in a dose- and time-dependent manner.
  • CXCL8 drove a G0/G1-to-G2/M phase transition in analyzed cells.
  • Identified several activated pathways associated with CXCL8 signaling.

Cite This Study

Wu et al. (2026) studied this question.

synapsesocial.com/papers/69ba42ae4e9516ffd37a3221https://doi.org/10.2147/ijwh.s569683
View Full Paper
Ask AI
Bookmark
Share